Mei Zhengrong and colleagues found that puerarin exhibits the ability to improve learning and memory deficits in APP/PS1 AD mouse models by reducing Aβ production and increasing P-GSK-3β expression (Zheng-rong et al., 2016). Here, APP is linked to Alzheimer disease.